Search
27/12/2022
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Izquierdo, CP, Mingot-Castellano, ME, Fuentes, AEK, Peinado, JGA, Cid, J, Jimenez, MM, Valcarcel, D, Gomez-Segui, I, de la Rubia, J, Martin, P, Goterris, R, Hernandez, L, Tallon, I, Varea, S, Fernandez, M, Garcia-Munoz, N, Vara, M, Zarzoso, MF, Garcia-Candel, F, Paciello, ML, Garcia-Garcia, I, Zalba, S, Campuzano, V, Gala, JM, Estevez, JV, Jimenez, GM, Lorenzo, JLL, Arias, EG, Freiria, C, Sole, M, Idrovo, LFA, Castellet, JCH, Cruz, N, Lavilla, E, PTrez-Montana, A, Atucha, JA, Beltran, MEM, Macias, JRM, Salinas, R, del Rio-Garma, J. Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura. Blood Advances. 2022; 6(24)DOI:10.1182/bloodadvances.2022008028. PMID:35930694. IF:7.500(Q1/2D).
27/12/2022
Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders
Margarit-Soler, A, Deya-Martinez, A, Canizales, JT, Vlagea, A, Garcia-Garcia, A, Marsal, J, Del Castillo, MT, Planas, S, Simo, S, Esteve-Sole, A, Grande, MSL, Badell, I, Tarrats, MR, Fernandez-Aviles, F, Alsina, L. Case report: Challenges in immune reconstitution following hematopoietic stem cell transplantation for CTLA-4 insufficiency-like primary immune regulatory disorders. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.1070068. PMID:36636328. IF:7.300(Q1/3D).
27/12/2022
Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Krychtiuk, KA, Ahrens, I, Drexel, H, Halvorsen, S, Hassager, C, Huber, K, Kurpas, D, Niessner, A, Schiele, F, Semb, AG, Sionis, A, Claeys, MJ, Barrabes, J, Montero, S, Sinnaeve, P, Pedretti, R, Catapano, A. Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European Heart Journal-Acute Cardiovascular Care. 2022; 11(12)DOI:10.1093/ehjacc/zuac123. PMID:36574353. IF:4.100(Q2/4D).
26/12/2022
Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study
Antequera, A, Cuadrado-Conde, MA, Roy-Vallejo, E, Montoya-Martinez, M, Leon-Garcia, M, Madrid-Pascual, O, Calderon-Larranaga, S. Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study. Systematic Reviews. 2022; 11(1)DOI:10.1186/s13643-021-01867-3. PMID:36572932. IF:3.700(Q2/4D).
26/12/2022
Diverse monogenic subforms of human spermatogenic failure
Nagirnaja, L, Lopes, AM, Charng, WL, Miller, B, Stakaitis, R, Golubickaite, I, Stendahl, A, Luan, TPC, Friedrich, C, Mahyari, E, Fadial, E, Kasak, L, Vigh-Conrad, K, Oud, MS, Xavier, MJ, Cheers, SR, James, ER, Guo, JT, Jenkins, TG, Riera-Escamilla, A, Barros, A, Carvalho, F, Fernandes, S, Goncalves, J, Gurnett, CA, Jorgensen, N, Jezek, D, Jungheim, ES, Kliesch, S, McLachlan, RI, Omurtag, KR, Pilatz, A, Sandlow, J, Smith, J, Eisenberg, ML, Hotaling, JM, Jarvi, KA, Punab, M, Rajpert-De Meyts, E, Carrell, DT, Krausz, C, Laan, M, O'Bryan, MK, Schlegel, PN, Tuttelmann, F, Veltman, JA, Almstrup, K, Aston, KI, Conrad, DF. Diverse monogenic subforms of human spermatogenic failure. Nature Communications. 2022; 13(1)DOI:10.1038/s41467-022-35661-z. PMID:36572685. IF:16.600(Q1/1D).
16/12/2022
Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
Ferraro, PM, Spotorno, N, Finegan, E, Sampedro, F, Caso, F. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.1100953. PMID:36588898. IF:3.400(Q2/5D).
16/12/2022
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients
Chicharro, P, Llamas-Velasco, M, Armesto, S, Acosta, EH, Vidal, D, Vilarrasa, E, Rivera-Diaz, R, De-la-Cueva, P, Martorell-Calatayud, A, Ballesca, F, Belinchon, I, Carretero, G, Rodriguez, L, Romero-Mate, A, Pujol-Montcusi, J, Salgado, L, Sahuquillo-Torralba, A, Coto-Segura, P, Rodriguez, OB, Feltes, R, Riera-Monroig, J, Dauden, E. Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients. Dermatologic Therapy. 2022; 35(12)DOI:10.1111/dth.15929. PMID:36223184. IF:3.600(Q1/3D).
15/12/2022
Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia
Guzman-Jimenez, A, Gonzalez-Munoz, S, Cervan-Martin, M, Rivera-Egea, R, Garrido, N, Lujan, S, Santos-Ribeiro, S, Castilla, JA, Gonzalvo, MC, Clavero, A, Vicente, FJ, Maldonado, V, Villegas-Salmeron, J, Burgos, M, Jimenez, R, Pinto, MG, Pereira, I, Nunes, J, Sanchez-Curbelo, J, Lopez-Rodrigo, O, Pereira-Caetano, I, Marques, PI, Carvalho, F, Barros, A, Bassas, L, Seixas, S, Goncalves, J, Lopes, AM, Larriba, S, Palomino-Morales, RJ, Carmona, FD, Bossini-Castillo, L. Contribution of TEX15 genetic variants to the risk of developing severe non-obstructive oligozoospermia. Frontiers in Cell and Developmental Biology. 2022; 10DOI:10.3389/fcell.2022.1089782. PMID:36589743. IF:5.500(Q1/2D).
14/12/2022
Influence of geographical latitude on vitamin D status: cross-sectional results from the BiomarCaRE consortium
Oskarsson, V, Eliasson, M, Salomaa, V, Reinikainen, J, Mannisto, S, Palmieri, L, Donfrancesco, C, Sans, S, Costanzo, S, de Gaetano, G, Iacoviello, L, Veronesi, G, Ferrario, MM, Padro, T, Thorand, B, Huth, C, Zeller, T, Blankenberg, S, Anderson, AS, Tunstall-Pedoe, H, Kuulasmaa, K, Soderberg, S. Influence of geographical latitude on vitamin D status: cross-sectional results from the BiomarCaRE consortium. BRITISH JOURNAL OF NUTRITION. 2022; 128(11)DOI:10.1017/S0007114521005080. PMID:34933700. IF:3.600(Q3/6D).
13/12/2022
Mutation update for the ACTN2 gene
Ranta-aho, J, Olive, M, Vandroux, M, Roticiani, G, Dominguez, C, Johari, M, Torella, A, Bohm, J, Turon, J, Nigro, V, Hackman, P, Laporte, J, Udd, B, Savarese, M. Mutation update for the ACTN2 gene. HUMAN MUTATION. 2022; 43(12)DOI:10.1002/humu.24470. PMID:36116040. IF:3.900(Q2/3D).
07/12/2022
Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model
Soliman, A, Chang, JR, Etminani, K, Byttner, S, Davidsson, A, Martinez-Sanchis, B, Camacho, V, Bauckneht, M, Stegeran, R, Ressner, M, Agudelo-Cifuentes, M, Chincarini, A, Brendel, M, Rominger, A, Bruffaerts, R, Vandenberghe, R, Kramberger, MG, Trost, M, Nicastro, N, Frisoni, GB, Lemstra, AW, van Berckel, BNM, Pilotto, A, Padovani, A, Morbelli, S, Aarsland, D, Nobili, F, Garibotto, V, Ochoa-Figueroa, M. Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model. BMC Medical Informatics and Decision Making. 2022; 22(SUPPL 6)DOI:10.1186/s12911-022-02054-7. PMID:36476613. IF:3.500(Q3/6D).
05/12/2022
Survey on the management of Pompe disease in routine clinical practice in Spain
Dominguez-Gonzalez, C, Diaz-Marin, C, Juntas-Morales, R, Nascimiento-Osorio, A, Rivera-Gallego, A, Diaz-Manera, J. Survey on the management of Pompe disease in routine clinical practice in Spain. Orphanet Journal of Rare Diseases. 2022; 17(1)DOI:10.1186/s13023-022-02574-5. PMID:36471448. IF:3.700(Q2/4D).
02/12/2022
Biologic treatment of psoriasis in oncologic patients
Rusinol, L, Camina-Conforto, G, Puig, L. Biologic treatment of psoriasis in oncologic patients. EXPERT OPINION ON BIOLOGICAL THERAPY. 2022; 22(12)DOI:10.1080/14712598.2022.2152322. PMID:36422998. IF:4.600(Q2/3D).
01/12/2022
Water T2 could predict functional decline in patients with dysferlinopathy
Moore, U, Araujo, ECD, Reyngoudt, H, Gordish-Dressman, H, Smith, FE, Wilson, I, James, M, Mayhew, A, Rufibach, L, Day, JW, Jones, KJ, Bharucha-Goebel, DX, Salort-Campana, E, Pestronk, A, Walter, MC, Paradas, C, Stojkovic, T, Mori-Yoshimura, M, Bravver, E, Pegoraro, E, Mendell, JR, Bushby, K, Blamire, AM, Straub, V, Carlier, PG, Diaz-Manera, J. Water T2 could predict functional decline in patients with dysferlinopathy. Journal of Cachexia Sarcopenia and Muscle. 2022; 13(6)DOI:10.1002/jcsm.13063. PMID:36058852. IF:8.900(Q1/1D).
01/12/2022
Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington's Disease
Sampedro, F, Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Horta-Barba, A, Campolongo, A, Izquierdo, C, Aracil-Bolanos, I, Rivas, E, Puig-Davi, A, Pagonabarraga, J, Gomez-Anson, B, Kulisevsky, J. Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington's Disease. Clinical Neuroradiology. 2022; 32(4)DOI:10.1007/s00062-022-01150-5. PMID:35238950. IF:2.800(Q2/5D).
01/12/2022
Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
Marin-Lahoz, J, Martinez-Horta, S, Pagonabarraga, J, Horta-Barba, A, Aracil-Bolanos, I, Bejr-kasem, H, Sampedro, F, Campolongo, A, Kulisevsky, J. Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers. ANNALS OF NEUROLOGY. 2022; 92(6)DOI:10.1002/ana.26486. PMID:36054656. IF:11.200(Q1/1D).
01/12/2022
Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy
De la Riva, P, Rodriguez-Antiguedad, J, Gomez, V, Arenaza, G, Gorostidi, A, Diez, N, De Arce, A, Martinez-Zabaleta, M, Gonzalez, F, Luttich, A, Garmendia, E, Sola, A, Larrea, JA, Bergareche, A, Sobrino, T. Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy. NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2022; 129DOI:10.1016/j.niox.2022.08.006. PMID:36067953. IF:3.900(Q2/5D).
01/12/2022
Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale
De Paepe, AE, Garcia-Gorro, C, Martinez-Horta, S, Perez, JP, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Santacruz, P, Munoz, E, Mareca, C, Ruiz-Idiago, J, De Diego-Balaguer, R, Camara, E. Delineating apathy profiles in Huntington's disease with the short-Lille Apathy Rating Scale. PARKINSONISM & RELATED DISORDERS. 2022; 105DOI:10.1016/j.parkreldis.2022.10.025. PMID:36395542. IF:4.100(Q2/3D).
01/12/2022
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
Pagonabarraga, J, Perez-Gonzalez, R, Bejr-kasem, H, Marin-Lahoz, J, Horta-Barba, A, Martinez-Horta, S, Aracil-Bolanos, I, Sampedro, F, Campolongo, A, Rivas, E, Puig-Davi, A, Ruiz-Barrios, I, Perez-Perez, J, Pascual-Sedano, B, Kulisevsky, J. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease. PARKINSONISM & RELATED DISORDERS. 2022; 105DOI:10.1016/j.parkreldis.2022.05.020. PMID:35752549. IF:4.100(Q2/3D).
01/12/2022
Trial of Deferiprone in Parkinson's Disease
Devos, D, Labreuche, J, Rascol, O, Corvol, JC, Duhamel, A, Delannoy, PG, Poewe, W, Compta, Y, Pavese, N, Ruzicka, E, Dusek, P, Post, B, Bloem, BR, Berg, D, Maetzler, W, Otto, M, Habert, MO, Lehericy, S, Ferreira, J, Dodel, R, Tranchant, C, Eusebio, A, Thobois, S, Marques, AR, Meissner, WG, Ory-Magne, F, Walter, U, de Bie, RMA, Gago, M, Vilas, D, Kulisevsky, J, Januario, C, Coelho, MVS, Behnke, S, Worth, P, Seppi, K, Ouk, T, Potey, C, Leclercq, C, Viard, R, Kuchcinski, G, Lopes, R, Pruvo, JP, Pigny, P, Garcon, G, Simonin, O, Carpentier, J, Rolland, AS, Nyholm, D, Scherfler, C, Mangin, JF, Chupin, M, Bordet, R, Dexter, DT, Fradette, C, Spino, M, Tricta, F, Ayton, S, Bush, AI, Devedjian, JC, Duce, JA, Cabantchik, I, Defebvre, L, Deplanque, D, Moreau, C. Trial of Deferiprone in Parkinson's Disease. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 387(22)DOI:10.1056/NEJMoa2209254. PMID:36449420. IF:158.500(Q1/1D).